Kohli, N., Lerner, M., Rashty, J., Kirke, D., Stewart, T., & Blitzer, A. (2022). IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial. American Journal of Otolaryngology, 43(6), 103613. https://doi.org/10.1016/j.amjoto.2022.103613